Name: HIV Rapid Test Kits Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Creator: DataM Intelligence
Published: Wed Jan 03 2024 11:33:32 GMT+0530 (India Standard Time)
License: https://www.datamintelligence.com/terms-conditions
Keywords: HIV Rapid Test Kits Market

HIV Rapid Test Kits Market Size, Share, Industry, Forecast and Outlook (2023-2030)

<h2>Global HIV Rapid Test Kits Market is Segmented By Technology (Lateral Flow Immunoassay, Immunofiltration), By Specimen (Blood, Urine, Oral Fluid), By Disease Type (HIV Type 1, HIV Type 2), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies),&nbsp;&nbsp;and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2023-2030.</h2>

<h3>HIV Rapid Test Kits Market Overview</h3>

<blockquote>
Global HIV Rapid Test Kits Market reached US$ YY&nbsp;billion in 2022 and is expected to reach US$ YY billion by 2030 growing with a CAGR of YY% during the forecast period 2023-2030.
</blockquote>

A rapid HIV test is useful for the detection of HIV at a faster rate usually in less than 30 minutes. It is a simple test to determine the antibodies in the oral fluids like blood and urine. HIV testing took a drastic shift from normal testing by drawing blood which takes a lot of time to rapid antigen testing which takes less than 30 minutes.

The test determines the type 1 HIV or type 2 which is dependent on the antigen present on the virus molecule. This is called differential detection. Although the results are faster, the accuracy of the standard tests is higher than the rapid ones.&nbsp;&nbsp;

<h3>HIV Rapid Test Kits Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Size Available for Years
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2021-2030
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2023-2030
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Data Availability
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Technology, Specimen, Disease Type, Distribution Channel
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/hiv-rapid-test-kits-market" target="_blank">Request for Sample</a>&nbsp;

&nbsp;

<h3>HIV Rapid Test Kits Market Dynamics</h3>

Rising prevalence of HIV-related cases

The worldwide incidence of HIV is high and is increasing at a very fast pace. For instance, according to the World Health Organization, the prevalence of HIV worldwide is very high with 39 million people living with it in 2022. Approximately 6,30,000 people die due to HIV-related illness in 2022. Women who are living with HIV are more with 20 million cases, men with 17.4 million, and children with 1.5 million cases in 2022. African regions are the most severely affected region with nearly 1 in every 25 adults living with HIV which accounts for more than two-thirds of the people living with HIV worldwide.&nbsp;

According to our World in Data Organization, 2023, over 1.5 % of deaths are caused by HIV globally which is more in lower-income countries like Africa due to the unavailability of disease diagnosis and treatment.

Furthermore, according to the UNICEF organization, as of 200 more than 14 children under the age of 18 lost one or both parents due to HIV and other AIDS-related causes. The epidemics are common in low-income country regions due to limitations in the diagnosis and treatment options for deadly diseases like HIV.

Inaccuracy of rapid test results

Point-of-care tests have a high rate of false negative and false positive results. As the results are produced within no time, there is high sensitivity.&nbsp; Although the test results are accurate, false positives and false negatives are possible which can lead to severe complications. According to the National Institute of Health, 2023, misdiagnosis of HIV using rapid test kits is prevalent by about 3.1% and false positive and false negative results are about 0.4%. The rapid test should be always followed by a standard HIV test due to its accuracy.&nbsp;

<h3>HIV Rapid Test Kits Market Segment Analysis</h3>

The global HIV rapid test kits are segmented based on technology, specimen, disease Type, distribution channel and region.

The lateral immuno assay Segment Accounted for Approximately 45.3% of the Market Share

Rapid enzyme immunoassays are the most commonly used for HIV screening tests. These enzyme immunoassays are rapid and can be used easily for the detection of HIV infection. The result is out quickly, within 30 minutes of usage which makes it more sensitive, rapid, and accurate and it can be easily used in home care settings. It detects the antibodies in the serum and provides accurate results hence, approved by the FDA. These are available in the form of small kits which makes them handy and portable. The launch of HIV rapid test kits increased due to the demand for these kits in the market.&nbsp;

For instance, in February 2023, Mylab launched new rapid test kits for the detection of HIV and other sexually transmitted diseases like hepatitis and syphilis.&nbsp;

In February 2022, the Thai Red Cross launched rapid-acting self-test kits to detect HIV. These kits are designed to combat social stigma around the diagnosis of HIV and its treatment.

<h3>Global HIV Rapid Test Kits Market Geographical Share</h3>

North America accounted for Approximately 42.7% of the Market Share in 2022

North America is expected to hold the largest share of the market due to the high incidence of HIV infections in the US and Canada.&nbsp;&nbsp;

According to the U.S. Department of Health &amp; Human Services, 2023, nearly 1.2 million people in the U.S. are suffering from HIV infection. About 13% are undiagnosed and left untreated. In 2021, there were 32,100 estimated new HIV infections in the U.S. and the rate was 11.5 (per 100,000 people).

In March 2023, according to the Oxford Academic Journal, 2023, individuals with 15-29 account for more than 1 quarter of new HIV cases in Canada.

<h3>COVID-19 Impact Analysis</h3>

COVID-19 impacted the HIV rapid test market due to an increase in the focus on COVID-19 treatment. The shift in the focus has decreased the diagnosis followed by the treatment of HIV. Several hospitals have seen a decrease in patient visits during the peak of the pandemic. The demand for rapid HIV self-tests decreased and shifted toward the covid 19 treatment.

Due to the rise in cases during the midst of the pandemic, there is the postponement of the diagnosis of deadly diseases like HIV, cancer, etc. The research and development on HIV halted, which impacted the advancements of test kits. However, after the COVID-19 infection came under control, rise in the focus on sectors like oncology and infectious diseases increased.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<h3>Key Developments</h3>

<ul>
	<li>In November 2022, Abbott launched new HIV home test kit, Panbio HIV Self-Test which is available over the counter which show the results within 20 minutes.&nbsp;&nbsp;</li>
	<li>In March 2023, Emory University launched a program to deliver 1 million rapid HIV self-tests across the country to raise awareness about HIV among people.&nbsp;&nbsp;</li>
</ul>

<h3>Competitive Landscape</h3>

The major global players in the HIV rapid test kits market include Biolytical Laboratories, Meril Life Sciences Pvt. Ltd., JOYSBIO (Tianjin) Biotechnology Co., Ltd, Alpine Biomedicals Pvt Ltd., Abbott Laboratories, Sedia Biosciences Corporation., Trivitron Healthcare, XIAMEN BOSON BIOTECH CO., LTD, F. Hoffmann-La Roche Ltd, and Viatris Inc. among others.

Why Purchase the Report?

To visualize the global HIV rapid test kits market based on technology, specimen, disease type, distribution channel, and region, as well as understand key commercial assets and players.

<ul>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of HIV rapid test kits market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global HIV rapid test kits market report would provide approximately 65 tables, 65 figures, and 195 Pages.

<h3>Target Audience 2023</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Technology</li>
		<li>Snippet by Specimen</li>
		<li>Snippet by Disease Type</li>
		<li>Snippet by Distribution Channel</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rising prevalence of HIV-related cases</li>
			</ol>
			</li>
			<li>Increasing incidence of autoimmune diseases&nbsp;</li>
			<li>Restraints
			<ol>
				<li>Inaccuracy of rapid test results</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Epidemiology Statistics</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Technology&nbsp;</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology&nbsp;</li>
			<li>Market Attractiveness Index, By Technology&nbsp;</li>
		</ol>
		</li>
		<li>Lateral Flow Immunoassay*
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Attractiveness Index, By Technology&nbsp;</li>
		</ol>
		</li>
		<li>Immunofiltration</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Specimen</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen</li>
			<li>Market Attractiveness Index, By Specimen</li>
		</ol>
		</li>
		<li>Blood
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen</li>
			<li>Market Attractiveness Index, By Specimen</li>
		</ol>
		</li>
		<li>Urine</li>
		<li>Oral Fluid</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Disease Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Attractiveness Index, By Disease Type</li>
		</ol>
		</li>
		<li>HIV Type 1
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Attractiveness Index, By Disease Type</li>
		</ol>
		</li>
		<li>HIV Type 2</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Distribution Channel</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Attractiveness Index, By Distribution Channel</li>
		</ol>
		</li>
		<li>Hospital Pharmacies*&nbsp;
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Retail Pharmacies</li>
		<li>Online Pharmacies</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Russia</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Biolytical Laboratories
		<ol>
			<li>Company Overview</li>
			<li>Technology Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Meril Life Sciences Pvt. Ltd.</li>
		<li>JOYSBIO (Tianjin) Biotechnology Co., Ltd&nbsp;</li>
		<li>Alpine Biomedicals Pvt Ltd.</li>
		<li>Abbott Laboratories</li>
		<li>Sedia Biosciences Corporation.</li>
		<li>Trivitron Healthcare</li>
		<li>XIAMEN BOSON BIOTECH CO., LTD</li>
		<li>F. Hoffmann-La Roche Ltd</li>
		<li>Viatris Inc.&nbsp;(*LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

&nbsp;

List of Tables

Table 1 Global HIV Rapid Test Kits Market Value, By Technology, 2022, 2026 &amp; 2030 (US$ Million)

Table 2 Global HIV Rapid Test Kits Market Value, By Specimen, 2022, 2026 &amp; 2030 (US$ Million)

Table 3 Global HIV Rapid Test Kits Market Value, By Disease Type, 2022, 2026 &amp; 2030 (US$ Million)

Table 4 Global HIV Rapid Test Kits Market Value, By Distribution Channel, 2022, 2026 &amp; 2030 (US$ Million)

Table 5 Global HIV Rapid Test Kits Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Million)

Table 6 Global HIV Rapid Test Kits Market Value, By Technology, 2021-2030 (US$ Million)

Table 7 Global HIV Rapid Test Kits Market Value, By Specimen, 2021-2030 (US$ Million)

Table 8 Global HIV Rapid Test Kits Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 9 Global HIV Rapid Test Kits Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 10 Global HIV Rapid Test Kits Market Value, By Region, 2022, 2026 &amp; 2030 (US$ Million)

Table 11 Global HIV Rapid Test Kits Market Value, By Region, 2021-2030 (US$ Million)

Table 12 North America HIV Rapid Test Kits Market Value, By Technology, 2021-2030 (US$ Million)

Table 13 North America HIV Rapid Test Kits Market Value, By Specimen, 2021-2030 (US$ Million)

Table 14 North America HIV Rapid Test Kits Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 15 North America HIV Rapid Test Kits Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 16 North America HIV Rapid Test Kits Market Value, By Country, 2021-2030 (US$ Million)

Table 17 South America HIV Rapid Test Kits Market Value, By Technology, 2021-2030 (US$ Million)

Table 18 South America HIV Rapid Test Kits Market Value, By Specimen, 2021-2030 (US$ Million)

Table 19 South America HIV Rapid Test Kits Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 20 South America HIV Rapid Test Kits Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 21 South America HIV Rapid Test Kits Market Value, By Country, 2021-2030 (US$ Million)

Table 22 Europe HIV Rapid Test Kits Market Value, By Technology, 2021-2030 (US$ Million)

Table 23 Europe HIV Rapid Test Kits Market Value, By Specimen, 2021-2030 (US$ Million)

Table 24 Europe HIV Rapid Test Kits Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 25 Europe HIV Rapid Test Kits Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 26 Europe HIV Rapid Test Kits Market Value, By Country, 2021-2030 (US$ Million)

Table 27 Asia-Pacific HIV Rapid Test Kits Market Value, By Technology, 2021-2030 (US$ Million)

Table 28 Asia-Pacific HIV Rapid Test Kits Market Value, By Specimen, 2021-2030 (US$ Million)

Table 29 Asia-Pacific HIV Rapid Test Kits Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 30 Asia-Pacific HIV Rapid Test Kits Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 31 Asia-Pacific HIV Rapid Test Kits Market Value, By Country, 2021-2030 (US$ Million)

Table 32 Middle East &amp; Africa HIV Rapid Test Kits Market Value, By Technology, 2021-2030 (US$ Million)

Table 33 Middle East &amp; Africa HIV Rapid Test Kits Market Value, By Specimen, 2021-2030 (US$ Million)

Table 34 Middle East &amp; Africa HIV Rapid Test Kits Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 35 Middle East &amp; Africa HIV Rapid Test Kits Market Value, By Distribution Channel, 2021-2030 (US$ Million)

Table 36 Biolytical Laboratories: Overview

Table 37 Biolytical Laboratories: Product Portfolio

Table 38 Biolytical Laboratories: Key Developments

Table 39 Meril Life Sciences Pvt. Ltd.: Overview

Table 40 Meril Life Sciences Pvt. Ltd.: Product Portfolio

Table 41 Meril Life Sciences Pvt. Ltd.: Key Developments

Table 42 JOYSBIO (Tianjin) Biotechnology Co., Ltd : Overview

Table 43 JOYSBIO (Tianjin) Biotechnology Co., Ltd : Product Portfolio

Table 44 JOYSBIO (Tianjin) Biotechnology Co., Ltd : Key Developments

Table 45 Alpine Biomedicals Pvt Ltd.: Overview

Table 46 Alpine Biomedicals Pvt Ltd.: Product Portfolio

Table 47 Alpine Biomedicals Pvt Ltd.: Key Developments

Table 48 Abbott Laboratories: Overview

Table 49 Abbott Laboratories: Product Portfolio

Table 50 Abbott Laboratories: Key Developments

Table 51 Sedia Biosciences Corporation.: Overview

Table 52 Sedia Biosciences Corporation.: Product Portfolio

Table 53 Sedia Biosciences Corporation.: Key Developments

Table 54 Trivitron Healthcare: Overview

Table 55 Trivitron Healthcare: Product Portfolio

Table 56 Trivitron Healthcare: Key Developments

Table 57 XIAMEN BOSON BIOTECH CO., LTD: Overview

Table 58 XIAMEN BOSON BIOTECH CO., LTD: Product Portfolio

Table 59 XIAMEN BOSON BIOTECH CO., LTD: Key Developments

Table 60 F. Hoffmann-La Roche Ltd: Overview

Table 61 F. Hoffmann-La Roche Ltd: Product Portfolio

Table 62 F. Hoffmann-La Roche Ltd: Key Developments

Table 63 Viatris Inc.: Overview

Table 64 Viatris Inc.: Product Portfolio

Table 65 Viatris Inc.: Key Developments

List of Figures

Figure 1 Global HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 2 Global HIV Rapid Test Kits Market Share, By Technology, 2022 &amp; 2030 (%)

Figure 3 Global HIV Rapid Test Kits Market Share, By Specimen, 2022 &amp; 2030 (%)

Figure 4 Global HIV Rapid Test Kits Market Share, By Disease Type, 2022 &amp; 2030 (%)

Figure 5 Global HIV Rapid Test Kits Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure 6 Global HIV Rapid Test Kits Market Share, By Region, 2022 &amp; 2030 (%)

Figure 7 Global HIV Rapid Test Kits Market Y-o-Y Growth, By Technology, 2022-2030 (%)

Figure 8 Lateral Flow Immunoassay HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 9 Immunofiltration HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 10 Global HIV Rapid Test Kits Market Y-o-Y Growth, By Specimen, 2022-2030 (%)

Figure 11 Blood Specimen in Global HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 12 Urine Specimen in Global HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 13 Oral Fluid Specimen in Global HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 14 Global HIV Rapid Test Kits Market Y-o-Y Growth, By Disease Type, 2022-2030 (%)

Figure 15 HIV Type 1 Disease Type in Global HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 16 HIV Type 2 Disease Type in Global HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 17 Global HIV Rapid Test Kits Market Y-o-Y Growth, By Distribution Channel, 2022-2030 (%)

Figure 18 Hospital Pharmacies in Global HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 19 Retail Pharmacies in Global HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 20 Online Pharmacies &nbsp; in Global HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 21 Global HIV Rapid Test Kits Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 22 North America HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 23 Asia-Pacific HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 24 Europe HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 25 South America HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 26 Middle East and Africa HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 27 North America HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 28 North America HIV Rapid Test Kits Market Share, By Technology, 2022 &amp; 2030 (%)

Figure 29 North America HIV Rapid Test Kits Market Share, By Specimen, 2022 &amp; 2030 (%)

Figure 30 North America HIV Rapid Test Kits Market Share, By Disease Type, 2022 &amp; 2030 (%)

Figure 31 North America HIV Rapid Test Kits Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure 32 North America HIV Rapid Test Kits Market Share, By Country, 2022 &amp; 2030 (%)

Figure 33 South America HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 34 South America HIV Rapid Test Kits Market Share, By Technology, 2022 &amp; 2030 (%)

Figure 35 South America HIV Rapid Test Kits Market Share, By Specimen, 2022 &amp; 2030 (%)

Figure 36 South America HIV Rapid Test Kits Market Share, By Disease Type, 2022 &amp; 2030 (%)

Figure 37 South America HIV Rapid Test Kits Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure 38 South America HIV Rapid Test Kits Market Share, By Country, 2022 &amp; 2030 (%)

Figure 39 Europe HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 40 Europe HIV Rapid Test Kits Market Share, By Technology, 2022 &amp; 2030 (%)

Figure 41 Europe HIV Rapid Test Kits Market Share, By Specimen, 2022 &amp; 2030 (%)

Figure 42 Europe HIV Rapid Test Kits Market Share, By Disease Type, 2022 &amp; 2030 (%)

Figure 43 Europe HIV Rapid Test Kits Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure 44 Europe HIV Rapid Test Kits Market Share, By Country, 2022 &amp; 2030 (%)

Figure 45 Asia-Pacific HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 46 Asia-Pacific HIV Rapid Test Kits Market Share, By Technology, 2022 &amp; 2030 (%)

Figure 47 Asia-Pacific HIV Rapid Test Kits Market Share, By Specimen, 2022 &amp; 2030 (%)

Figure 48 Asia-Pacific HIV Rapid Test Kits Market Share, By Disease Type, 2022 &amp; 2030 (%)

Figure 49 Asia-Pacific HIV Rapid Test Kits Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure 50 Asia-Pacific HIV Rapid Test Kits Market Share, By Country, 2022 &amp; 2030 (%)

Figure 51 Middle East &amp; Africa HIV Rapid Test Kits Market Value, 2021-2030 (US$ Million)

Figure 52 Middle East &amp; Africa HIV Rapid Test Kits Market Share, By Technology, 2022 &amp; 2030 (%)

Figure 53 Middle East &amp; Africa HIV Rapid Test Kits Market Share, By Specimen, 2022 &amp; 2030 (%)

Figure 54 Middle East &amp; Africa HIV Rapid Test Kits Market Share, By Disease Type, 2022 &amp; 2030 (%)

Figure 55 Middle East &amp; Africa HIV Rapid Test Kits Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure 56 Biolytical Laboratories: Financials

Figure 57 Meril Life Sciences Pvt. Ltd.: Financials

Figure 58 JOYSBIO (Tianjin) Biotechnology Co., Ltd: Financials

Figure 59 Alpine Biomedicals Pvt Ltd.: Financials

Figure 60 Abbott Laboratories: Financials

Figure 61 Sedia Biosciences Corporation.: Financials

Figure 62 Trivitron Healthcare: Financials

Figure 63 XIAMEN BOSON BIOTECH CO., LTD: Financials

Figure 64 F. Hoffmann-La Roche Ltd: Financials

Figure 65 Viatris Inc.: Financials

&nbsp;

HIV Rapid Test Kits Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Clinical Diagnostics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 28

Starting from

HIV Diagnostics Testing Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 February 03

Starting from

Radioimmunoassay Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 January 02

Starting from

Chemiluminescence Immunoassay Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 November 11

Starting from